Do background ischemic heart disease and baseline left ventricular ejection fraction affect cardiovascular efficacy of SGLT-2 inhibitors in heart failure with reduced ejection fraction?

Second Propedeutic Department of Internal Medicine. Third Department of Cardiology. Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital 'Hippokration', Thessaloniki, Greece. Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia, USA.

Journal of cardiovascular medicine (Hagerstown, Md.). 2022;(1):e30-e32

Methodological quality

Publication Type : Meta-Analysis

Metadata